Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-24 @ 5:20 PM
NCT ID:
NCT06132750
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to complete (part of) the measurement protocol at the Radboudumc, Nijmegen. If patients do not wish or not able to visit our neuromuscular center, they are offered to participate in our study through home visits.
* Genetic conformation of LAMA2-related muscular dystrophy or SELENON-related myopathy by two recessive (likely) pathologic mutations in the LAMA2 or SELENON gene.
* Typical clinical and histological characteristics combined with genetic confirmation in a first degree relative.
* Dutch speaking
Exclusion Criteria:
* Insufficient understanding of the Dutch language
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
100 Years
Study:
NCT06132750
Study Brief:
Protocol Section:
NCT06132750